Research Analysts’ New Coverage for October 15th (ALNY, ARQT, ARWR, BMRN, CAMP, COAG, DRUG, ENIC, FIS, FISV)

Research Analysts’ new coverage for Thursday, October 15th:

UBS Group AG assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). They issued a buy rating and a $354.00 target price on the stock.

Cantor Fitzgerald began coverage on shares of Arcutis Biotherapeutics (NASDAQ:ARQT). Cantor Fitzgerald issued an overweight rating and a $48.00 price target on the stock.

UBS Group AG began coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR). The firm issued a buy rating and a $109.00 price target on the stock.

UBS Group AG started coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). UBS Group AG issued a buy rating and a $88.00 price target on the stock.

Needham & Company LLC began coverage on shares of CAMP4 Therapeutics (NASDAQ:CAMP). Needham & Company LLC issued a buy rating and a $8.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of Hemab Therapeutics (NASDAQ:COAG). They issued an overweight rating and a $70.00 price target on the stock.

Wolfe Research assumed coverage on shares of Bright Minds Biosciences (NASDAQ:DRUG). They issued an outperform rating and a $150.00 target price on the stock.

Bank of America Corporation initiated coverage on shares of Enel Chile (NYSE:ENIC). The firm issued a neutral rating on the stock.

Bank of America Corporation started coverage on shares of Fidelity National Information Services (NYSE:FIS). The firm issued a buy rating and a $42.00 price target on the stock.

Bank of America Corporation started coverage on shares of Fiserv (NASDAQ:FISV). Bank of America Corporation issued an underperform rating and a $48.00 price target on the stock.

Bank of America Corporation assumed coverage on shares of Shift4 Payments (NYSE:FOUR). The firm issued a neutral rating and a $42.00 target price on the stock.

Bank of America Corporation began coverage on shares of Global Payments (NYSE:GPN). They issued a buy rating and a $114.00 price target on the stock.

LADENBURG THALM/SH SH started coverage on shares of Harmony Biosciences (NASDAQ:HRMY). They issued a buy rating and a $55.00 price target on the stock.

Bank of America Corporation assumed coverage on shares of Jack Henry & Associates (NASDAQ:JKHY). The firm issued a neutral rating and a $165.00 target price on the stock.

JPMorgan Chase & Co. began coverage on shares of MGE Energy (NASDAQ:MGEE). The firm issued a neutral rating and a $76.00 target price on the stock.

Scotiabank started coverage on shares of Matador Resources (NYSE:MTDR). They issued a sector perform rating and a $59.00 price target on the stock.

Citizens Jmp started coverage on shares of Vail Resorts (NYSE:MTN). Citizens Jmp issued a market perform rating on the stock.

Jefferies Financial Group Inc. started coverage on shares of NorthWestern (NASDAQ:NWE). Jefferies Financial Group Inc. issued a buy rating and a $85.00 price target on the stock.

Bank of America Corporation initiated coverage on shares of PayPal (NASDAQ:PYPL). The firm issued an underperform rating on the stock.

Wolfe Research started coverage on shares of Rapport Therapeutics (NASDAQ:RAPP). They issued an outperform rating and a $50.00 price target on the stock.

UBS Group AG assumed coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE). They issued a neutral rating and a $16.00 target price on the stock.

HC Wainwright assumed coverage on shares of Sight Sciences (NASDAQ:SGHT). They issued a buy rating and a $14.00 target price on the stock.

UBS Group AG assumed coverage on shares of Spectrum Brands (NYSE:SPB). They issued a buy rating and a $97.00 target price on the stock.

Needham & Company LLC initiated coverage on shares of Suja Life (NASDAQ:SUJA). They issued a buy rating on the stock.

Bank of America Corporation initiated coverage on shares of Toast (NYSE:TOST). The firm issued a buy rating and a $40.00 price target on the stock.